Möchten Sie immer auf dem neuesten Stand bleiben?

Pulse Report shows how AI-powered drug discovery, trial optimization, and precision medicine are accelerating innovation while cutting costs and timelines.

Initiation of the TRICURE US IDE pivotal study represents the first of next-generation TTVR devices to enroll patients in the US  Minneapolis, MN, USA and Paris, France and Munich, Germany, 9 July...

Examines the evolving competitive landscape, regulatory developments & investment trends shaping the future of chronic kidney disease management worldwide.

Neutra Corp’s Subsidiary Neutra Life Sciences Executes New Women’s Health Joint Venture and Expands Trial Portfolio

BCC Research analyzes patent activity, clinical trials, AI adoption and competitive dynamics shaping the global cardiovascular drugs market through 2030.

Austin, TX, USA, June 19, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “ECG Patch and Holter Monitor Market Size, Trends and Insights By Product Type...

Thanks to the support of the Linda and Mike Mussallem Foundation, Octane has launched the Octane Mussallem Cardiovascular Accelerator.

Cardiawave Announces First Routine Treatments Performed with Valvosoft® Following CE Mark Approval and Accelerates Its Deployment

Repairon announces NEJM publication concluding that heart muscle restoration is achievable in patients, resulting in improved health and quality of life.

Paris, France, May 19, 2026 (GLOBE NEWSWIRE) -- Significantly lower TLF rates (2.8% versus 7.8%, p=0.020) with DynamX® compared to Resolute Onyx DES with no new events in bioadaptor arm between 3...